NIH Weekly Funding Opportunities and Policy Notices
Funding Opportunity RFA-DK-22-501 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites a renewal application from UH3 DK118748 supported by RFA-RM-16-019. This FOA will support the continuation and completion of HiLo: A pragmatic trial of higher vs lower serum phosphate targets in patients undergoing hemodialysis. The awardee will continue to enroll and follow hemodialysis patients in the HiLo trial to its completion.
Funding Opportunity RFA-DK-22-509 from the NIH Guide for Grants and Contracts. The Diabetic Foot Consortium (DFC) is the first clinical network for the study of diabetic foot ulcers (DFUs) a common, expensive, and debilitating complication of diabetes that leads to over 100,000 amputations in the United States every year. The DFC was started to address this significant public health problem by building a research infrastructure and validating biomarkers to predict healing or recurrence of DFUs. This Limited Competition Funding Opportunity Announcement (FOA) calls for the renewal of the Clinical Research Units (CRUs) for their support of an expansion of the mission of the DFC with the following goals: 1) develop and validate biomarkers for DFUs;2) accelerate advances in DFU standard care; 3) characterize the role of social determinants of health for DFU healing and recurrence; and 4) build on the DFC infrastructure through ancillary studies and satellite sites. Future research may involve clinical trials and studies on the pathophysiology and prevention of DFUs. All protocol interactions in the DFC will occur at the CRUs. They will recruit participants, collect longitudinal data, images and biosamples and send these data and biosamples to the Data Coordinating Center and Biomarker Analysis Units. They will also collaborate with Satellite sites to accelerate the pace of the DFC studies. As members of the Steering Committee, they will provide leadership in developing protocols and setting priorities for the DFC to best leverage its resources to improve clinical research and care for DFUs.
Notice NOT-HD-22-024 from the NIH Guide for Grants and Contracts
Notice NOT-CA-22-089 from the NIH Guide for Grants and Contracts
Notice NOT-HS-22-017 from the NIH Guide for Grants and Contracts
Notice NOT-HS-22-016 from the NIH Guide for Grants and Contracts
Notice NOT-HD-22-009 from the NIH Guide for Grants and Contracts
Notice NOT-OD-22-137 from the NIH Guide for Grants and Contracts
Notice NOT-NS-22-105 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-NS-22-051 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits applications for a Data Management and Coordinating Center (DMCC) to provide infrastructure, data management, and clinical research support for a new network of clinical sites that provide diagnostic services for undiagnosed diseases. The new Network is intended to sustain some of the key research activities currently performed by the Undiagnosed Diseases Network (UDN), an NIH Common Fund program that was established in 2013 and will sunset in 2023. The DMCC will coordinate clinical sites that apply to join the new Network beginning in FY2023 as Diagnostic Centers of Excellence (DCoEs) through a related Resource Access Program (X01) mechanism. The DMCC will support the DCoEs and the NIH intramural Undiagnosed Diseases Program (UDP) by coordinating trans-network research activities, with services managed across three Cores: 1) Administrative Core; 2) Data Management Core, and 3) Clinical Research Support Core.
Funding Opportunity RFA-DK-22-006 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite applications to support institutional career development programs in urological research that will assist individuals with doctorate degrees (either clinical or professional) with an interest in benign urological disease or urological research to develop the skills necessary to initiate and sustain an independent research career in urological research. Research areas supported by this initiative must be related to the mission of the NIDDK (https://www.niddk.nih.gov/research-funding/research-programs#urologic-diseases).
Notice NOT-HG-22-014 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-ES-22-003 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits applications from eligible institutions to develop a?Research Coordinating Center (RCC) to support the development of an NIH CCH Community of Practice by managing and supporting current and future CCH research and capacity building efforts. The RCC will create a robust inclusive CCH-COP that fosters collaboration, capacity building, innovation and research that aligns with the NIH CCH initiative. The RCC will offer opportunities for collaboration between multiple disciplines required to conduct solutions-driven research on the health impacts of climate change. The four functions of the RCC are administrative oversight, resource development, data management, and research capacity building.
Notice NOT-OD-22-141 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-DA-23-015 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) will support projects proposing mechanistic studies that will transform our understanding of polysubstance use in addiction. These hypothesis-based, exploratory projects may investigate mechanisms of polysubstance use at the behavioral, cognitive, cellular, circuit, genetic, epigenetic, pharmacological and/or computational levels.
Funding Opportunity PA-22-176 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA), issued by the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), and the Food and Drug Administration (FDA), invites eligible United States small businesses to submit Small Business Innovation Research (SBIR) grant applications. United States small businesses that have the research capabilities and technological expertise to contribute to the R and D mission(s) of the NIH, CDC, and FDA awarding components identified in this FOA are encouraged to submit SBIR grant applications in response to identified topics (see PHS 2022-2 SBIR/STTR Program Descriptions and Research Topics for NIH, CDC, and FDA. This Parent Funding Opportunity Announcement does not accept clinical trials.
Funding Opportunity PA-22-177 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA), issued by the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) invites eligible United States small businesses to submit Small Business Innovation Research (SBIR) grant applications. United States small businesses that have the research capabilities and technological expertise to contribute to the R and D mission(s) of the NIH and CDC awarding components identified in this FOA are encouraged to submit SBIR grant applications in response to identified topics (see PHS 2022-2 SBIR/STTR Program Descriptions and Research Topics for NIH, CDC, and FDA). This Parent Funding Opportunity Announcement requires that at least 1 clinical trial be proposed. The proposed project must be related to the programmatic interests of one or more of the participating NIH Institutes and Centers (ICs) based on their scientific missions.
Funding Opportunity PA-22-178 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA), issued by the National Institutes of Health (NIH) invites eligible United States small businesses to submit Small Business Technology Transfer (STTR) grant applications. United States small businesses that have the research capabilities and technological expertise to contribute to the R and D mission(s) of the NIH awarding components identified in this FOA are encouraged to submit STTR grant applications in response to identified topics (see PHS 2022-2 SBIR/STTR Program Descriptions and Research Topics for NIH, CDC, and FDA). This Parent Funding Opportunity Announcement does not accept clinical trials.
Funding Opportunity PA-22-179 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA), issued by the National Institutes of Health (NIH) invites eligible United States small businesses to submit Small Business Technology Transfer (STTR) grant applications. United States small businesses that have the research capabilities and technological expertise to contribute to the R and D mission(s) of the NIH awarding components identified in this FOA are encouraged to submit STTR grant applications in response to identified topics (see PHS 2022-2 SBIR/STTR Program Descriptions and Research Topics for NIH, CDC, and FDA). This Parent Funding Opportunity Announcement requires that at least 1 clinical trial be proposed. The proposed project must be related to the programmatic interests of one or more of the participating NIH Institutes and Centers (ICs) based on their scientific missions.
Notice NOT-CE-22-002 from the NIH Guide for Grants and Contracts